Biofarm S.A. (BVB:BIO)
1.370
+0.010 (0.74%)
At close: Aug 24, 2026
Biofarm Revenue
Biofarm had revenue of 45.34M RON in the quarter ending June 30, 2026, a decrease of -33.16%. This brings the company's revenue in the last twelve months to 294.25M, down -4.62% year-over-year. In the year 2025, Biofarm had annual revenue of 319.33M with 11.36% growth.
Revenue (ttm)
294.25M
Revenue Growth
-4.62%
P/S Ratio
4.59
Revenue / Employee
786.78K
Employees
374
Market Cap
1.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 319.33M | 32.56M | 11.36% |
| Dec 31, 2024 | 286.77M | 6.48M | 2.31% |
| Dec 31, 2023 | 280.29M | 3.31M | 1.19% |
| Dec 31, 2022 | 276.98M | 37.94M | 15.87% |
| Dec 31, 2021 | 239.04M | 22.62M | 10.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Alro S.A. | 4.30B |
| Sphera Franchise Group | 1.59B |
| Teraplast | 1.11B |
| Chimcomplex | 1.00B |
| Fondul Proprietatea | 671.33M |
| TTS (Transport Trade Services) | 656.70M |
| Antibiotice | 616.58M |
| Infinity Capital Investments | 277.14M |